Liquid Biopsies Congress
Category Oncology; Liquid Biopsy; immuno-oncology; cfDNA
Deadline: October 04, 2019 | Date: October 10, 2019-October 11, 2019
Venue/Country: London Heathrow Marriott Hotel, U.K.
Updated: 2019-01-22 21:55:17 (GMT+9)
Call For Papers - CFP
Liquid Biopsies can provide additional patient data less invasively than standard tissue biopsies. The integration of liquid biopsies into clinical practice will enable a greater understanding of the patient through faster disease detection, earlier diagnosis, enhanced disease monitoring and treatment response and therefore delivering enhanced personalized healthcare.This conference offers the biopharmaceutical industry the opportunity to examine the latest developments in the field with dedicated congress presentations, panel discussions and roundtables that study novel methods, research techniques, advances and discoveries in the field, through research applications utilizing technologies such as qPCR, Digital PCR and NGS.With presentations on circulating biomarkers such as cell-free DNA, (cfDNA), circulation tumor cells (CTCs), and extracellular vesicles (EVs) this meeting will allow you to keep up to date with the cutting edge of research and the opportunity to further knowledge and business partnerships with those in your field.Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.